Our Therapeutics Pipeline
Current research works
Our current research works
In Silico – In Vitro – In Vivo
Since the beginning of 2022 CancerAppy has focused on the discovery and development of new therapeutic targets in cancer.
All this thanks to the development of our AI platform in collaboration with our scientific advisors.
The rapid growth of the internal pipeline demonstrates the great drug discovery capabilities driven by the use of our AI platform.
Likewise, our partners and collaborators take advantage of our technology and high scientific knowledge to increase and accelerate their initiatives for the discovery and development of new drugs against cancer.
Target Identification
We combine our expertise in biology and AI to identify new therapeutic targets.
Lead Identification
We combine our expertise in chemistry and AI to identify new chemical compounds with the potential to be novel inhibitors of therapeutic targets.
Mechanism of action
We can find the possible mechanism of action of a compound.
The programs below are progressing into the early preclinical stage.
However they are programs that are available under CDA.
Contact us for partnership opportunities.
Request an Interview
We would be happy to help you.
